---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005988"
form_type: "8-K"
ticker: "PAYS"
cik: "0001496443"
company_name: "Paysign, Inc."
filed_at: "2026-08-05T20:05:47+00:00"
generated_at: "2026-08-05T20:08:06.942789+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Paysign reports record Q2 revenue $28.3M (+48%), raises FY2026 outlook

## Summary
- Revenue $28.25M, up 48.1% YoY; GAAP net income $6.76M ($0.11 EPS) vs $1.39M ($0.02) prior year.
- Pharma revenue $14.65M (+88.9%) with 148 active programs; plasma revenue $13.04M (+21.4%) with 561 centers.
- Adjusted EBITDA $9.61M, up 113%; operating margin 24.8% (21.3% ex contingent consideration).
- Raised FY2026 revenue guidance to $114-117M and adjusted EBITDA to $35-38M.
- Balance sheet: $27.37M unrestricted cash, zero bank debt.

## SEC filing metadata
- accession: 0001683168-26-005988
- form_type: 8-K
- ticker: PAYS
- cik: 0001496443
- company_name: Paysign, Inc.
- filed_at: 2026-08-05T20:05:47+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1496443/000168316826005988/0001683168-26-005988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1496443/000168316826005988/paysign_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005988
- JSON: https://secwatch.observer/filing/0001683168-26-005988.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.